Full Text View
Tabular View
No Study Results Posted
Related Studies
TOBY: a Study of Treatment for Perinatal Asphyxia
This study has been completed.
Study NCT00147030   Information provided by Imperial College London
First Received: September 5, 2005   Last Updated: April 17, 2009   History of Changes

September 5, 2005
April 17, 2009
December 2002
November 2006   (final data collection date for primary outcome measure)
Combined incidence of mortality and severe neurodevelopmental disability in survivors [ Time Frame: 18 months ]
Combined incidence of mortality and severe neurodevelopmental disability in survivors at 18 months of age.
Complete list of historical versions of study NCT00147030 on ClinicalTrials.gov Archive Site
  • Intracranial haemorrhage [ Time Frame: Before discharge from hospital ]
  • Persistent hypotension [ Time Frame: Before discharge from hospital ]
  • Pulmonary haemorrhage [ Time Frame: Before discharge from hospital ]
  • Pulmonary hypertension [ Time Frame: Before discharge from hospital ]
  • Prolonged blood coagulation time [ Time Frame: Before discharge from hospital ]
  • Culture proven sepsis [ Time Frame: Before discharge from hospital ]
  • Necrotising enterocolitis [ Time Frame: Before discharge from hospital ]
  • Cardiac arrhythmia [ Time Frame: Before discharge from hospital ]
  • Thrombocytopenia [ Time Frame: Before discharge from hospital ]
  • Major venous thrombosis [ Time Frame: Before discharge from hospital ]
  • Renal failure treated with dialysis [ Time Frame: Before discharge from hospital ]
  • Pneumonia [ Time Frame: Before discharge from hospital ]
  • Pulmonary airleak [ Time Frame: Before discharge from hospital ]
  • Duration of hospitalisation [ Time Frame: Before discharge from hospital ]
  • Mortality [ Time Frame: 18 months ]
  • Severe neurodevelopmental disability [ Time Frame: 18 months ]
  • Multiple handicap (defined as the presence of any two of the following in an infant; neuromotor disability (Level 3-5 on GMF classification), mental delay (Bayley MDI score < 70), epilepsy, cortical visual impairment, sensorineural hearing loss) [ Time Frame: 18 months ]
  • Bayley PDI score [ Time Frame: 18 months ]
  • Sensorineural hearing loss: 40 dB [ Time Frame: 18 months ]
  • Epilepsy (defined as recurrent seizures beyond the neonatal period, requiring anticonvulsant therapy at the time of assessment) [ Time Frame: 18 months ]
  • Microcephaly (head circumference more than 2 standard deviations below the mean). [ Time Frame: 18 months ]
  • 1. Intracranial haemorrhage
  • 2. Persistent hypotension
  • 3. Pulmonary haemorrhage
  • 4. Pulmonary hypertension
  • 5. Prolonged blood coagulation time
  • 6. Culture proven sepsis
  • 7. Necrotising enterocolitis
  • 8. Cardiac arrhythmia
  • 9. Thrombocytopenia
  • 10. Major venous thrombosis
  • 11. Renal failure treated with dialysis
  • 12. Pneumonia
  • 13. Pulmonary airleak
  • 14. Duration of hospitalisation
  • Long term (at 18 months):
  • 1. Mortality
  • 2. Severe neurodevelopmental disability
  • 3. Multiple handicap (defined as the presence of any two of the following in an infant; neuromotor disability (Level 3-5 on GMF classification), mental delay (Bayley MDI score < 70), epilepsy, cortical visual impairment, sensorineural hearing loss)
  • 4. Bayley PDI score
  • 5. Sensorineural hearing loss: 40 dB
  • 6. Epilepsy (defined as recurrent seizures beyond the neonatal period, requiring anticonvulsant therapy at the time of assessment)
  • 7. Microcephaly (head circumference more than 2 standard deviations below the mean).
 
TOBY: a Study of Treatment for Perinatal Asphyxia
Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy

Hypothesis: Prolonged whole body cooling in term infants with perinatal asphyxial encephalopathy reduces death and severe neurodevelopmental disability.

This study aims to determine whether whole body cooling to 33-34°C is a safe treatment that improves survival, without severe neurological or neurodevelopmental impairments at 18 months, of term infants suffering perinatal asphyxial encephalopathy.

This is a multicentre prospective randomised controlled trial to determine whether a reduction of body temperature by 3-4°C following perinatal asphyxia improves survival without neurodevelopmental disability.

Full term infants will be randomised within 6 hours of birth to either a control group with the rectal temperature kept at 37 ± 0.2°C or to whole body cooling with the rectal temperature kept at 33.5 ± 0.5°C for 72 hours followed by slow rewarming.

The outcome will be assessed at 18 months of age by survival and neurological and neurodevelopmental testing.

Eligibility criteria:

Term infants less than 6 hours after birth with moderate or severe perinatal asphyxia (a combination of clinical and EEG criteria).

Exclusion criteria:

Infants expected to be 6 hours of age at the time of randomisation or infants with major congenital abnormalities.

Intervention:

Intensive care with whole body cooling versus intensive care without whole body cooling (babies are cooled to 33.5°C for 72 hours)

Main Outcomes:

Death and severe neurodevelopmental impairment at 18 months of age

Secondary Outcomes:

Cerebral thrombosis or haemorrhage, persistent hypotension, pulmonary hypertension, abnormal coagulation, arrhythmia and sepsis in the neonatal period. Neurological impairments at 18 months

Number of patients required: 236.

On 30th November 2006, when recruitment closed, 325 babies had been recruited.

 
Interventional
Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
  • Asphyxia Neonatorum
  • Hypoxia
  • Encephalopathy
  • Seizures
Procedure: Whole body mild induced hypothermia
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
325
August 2008
November 2006   (final data collection date for primary outcome measure)

Inclusion criteria

The infant will be assessed sequentially by criteria A, B and C listed below:

A. Infants =>36 completed weeks gestation admitted to the NICU with at least one of the following:

  • Apgar score of =<5 at 10 minutes after birth
  • Continued need for resuscitation, including endotracheal or mask ventilation, at 10 minutes after birth
  • Acidosis within 60 minutes of birth (defined as any occurrence of umbilical cord, arterial or capillary pH <7.00)
  • Base Deficit =>16 mmol/L in umbilical cord or any blood sample (arterial, venous or capillary) within 60 minutes of birth

Infants that meet criteria A will be assessed for whether they meet the neurological abnormality entry criteria (B) by trained personnel:

B. Moderate to severe encephalopathy, consisting of altered state of consciousness (lethargy, stupor or coma) AND at least one of the following:

  • hypotonia
  • abnormal reflexes including oculomotor or pupillary abnormalities
  • absent or weak suck
  • clinical seizures

Infants that meet criteria A & B will be assessed by aEEG (read by trained personnel):

C. At least 30 minutes duration of amplitude integrated EEG recording that shows abnormal background aEEG activity or seizures. There must be one of the following:

  • normal background with some seizure activity
  • moderately abnormal activity
  • suppressed activity
  • continuous seizure activity

Exclusion criteria

  • Infants expected to be > 6 hours of age at the time of randomisation
  • Major congenital abnormalities, such as diaphragmatic hernia requiring ventilation, or congenital abnormalities suggestive of chromosomal anomaly or other syndromes that include brain dysgenesis
Both
up to 6 Hours
No
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
NCT00147030
 
ISRCTN89547571
Imperial College London
Medical Research Council
Principal Investigator: Denis Azzopardi, MD; FRCPCH Imperial College London
Imperial College London
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP